MedTrace Logo

REPI : a Randomized Open Label Trial Evaluating the Use of APC in Pre-Implantation Reconstruction of Maxilla

NCT00295126 · Status: TERMINATED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2008-03-14

No results posted yet for this study

Summary

This is a randomized open label trial that evaluates the efficacy of an autologous platelet concentrate (APC) in pre-implantation reconstruction of maxilla.

The sinus occlusion will be performed under general anaesthetic. On one side by the usual technique with hipbone transplant, the other side will be restored with APC mixed with autologous bone tissue removed from the surgery site.

The side selection will be determined by the randomization.

Conditions

  • Jaw, Edentulous
  • Tooth Loss
  • Maxillary Diseases

Interventions

PROCEDURE

cellular therapy : Autologous platelet concentrate (APC)

Sponsors & Collaborators

  • Etablissement Français du Sang

    collaborator OTHER

  • University Hospital, Grenoble

    lead OTHER

Principal Investigators

  • Georges Bettega, Dr · Univesity Grenoble Hospital, Stomatology Department

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-05-31
Completion
2007-11-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00295126 on ClinicalTrials.gov